Squarepoint’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Other funds holding TXMD
CWG
RCMNY
Squarepoint's TXMD Position: Q1 2022 in Review
Squarepoint sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 2,734 shares — an estimated $49K sold.
Squarepoint first reported a position in TXMD in Q4 2015 and held it in 17 quarters. The position peaked at $898K in Q2 2020. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.
- Squarepoint reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
- Squarepoint sold 2,734 TherapeuticsMD shares in Q1 2022, an estimated $49K.
- Squarepoint first reported a position in TherapeuticsMD in Q4 2015 and held it in 17 quarters.
- Squarepoint's TherapeuticsMD position peaked at $898K in Q2 2020.
- 124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.
Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.